Wednesday, September 23, 2026

Technology

797 articles

C3.ai AI Stock Rebounds: Is It Time to Buy Now?

C3.ai AI Stock Rebounds: Is It Time to Buy Now?

C3.ai shares have rebounded 6% after a recent decline, sparking questions about whether it's an undervalued opportunity. With a year-to-date loss of 60.69%, investors are reassessing growth prospects. The stock's price-to-sales ratio of 5x is above industry averages, raising concerns about relative valuation.

Via News Editorial
Adobe Faces Volatility as Market Watches for Future Growth

Adobe Faces Volatility as Market Watches for Future Growth

Adobe shares have edged upward in recent trading despite a lack of headline news. Investors are closely monitoring the company's valuation following a sharp decline earlier this year. With a 1-year total shareholder return of -36.7%, Adobe remains a key watch for its long-term growth potential.

Via News Editorial
Opendoor Technologies Stock Plummets Amid Broader Market Uncertainty

Opendoor Technologies Stock Plummets Amid Broader Market Uncertainty

Opendoor Technologies (OPEN) stock dropped this week as investors became bearish amid macroeconomic concerns. The company's share price fell 16.9% in intraday trading, despite its strong 2025 outlook. Analysts highlight 10 better stocks for investors to consider.

Via News Editorial
AI Stocks Set to Outperform Apple by 2026: Key Analysis

AI Stocks Set to Outperform Apple by 2026: Key Analysis

AI stocks Alphabet and Microsoft are poised to outperform Apple by year-end 2026, according to a detailed analysis. With faster growth and lower valuations, these stocks are expected to surpass Apple's market cap.

Via News Editorial
Asian Growth Companies with Up to 31% Insider Ownership Show Strong Earnings Growth

Asian Growth Companies with Up to 31% Insider Ownership Show Strong Earnings Growth

Asian markets are experiencing volatility, particularly in technology-driven sectors. Companies with strong insider ownership, such as Seers Technology and Novoray, are attracting attention due to their high earnings growth rates. This article explores the implications of high insider ownership and the growth potential of these companies.

Via News Editorial
DocuSign Stock Rallies Amid Policy Shifts: Will Growth Outlook Change?

DocuSign Stock Rallies Amid Policy Shifts: Will Growth Outlook Change?

DocuSign's shares have rallied as investors anticipate potential easing of interest rates, boosting the present value of future earnings. However, the company's lower P/E ratio suggests caution and possible undervaluation. The upcoming integration with ChatGPT could shape future growth, but competition in digital agreements remains a key risk.

Via News Editorial
AMD vs. Intel: Which Chipmaker Is Poised for Explosive Data Center Growth?

AMD vs. Intel: Which Chipmaker Is Poised for Explosive Data Center Growth?

AMD and Intel are at the forefront of data center competition as AI infrastructure continues to grow. AMD's MI300 and MI400 GPUs have seen significant success, while Intel's data center business has struggled. With $4.3 billion in revenue for AMD and $4.1 billion for Intel in the third quarter of 2025, AMD's full-stack approach could provide a strategic advantage over Intel.

Via News Editorial
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com